Justin Yssel

Pharmacological targeting of β₂‐adrenoceptors is neuroprotective in the LPS inflammatory rat model of Parkinson's disease

Eoin O′Neill, Justin Yssel, Caoimhe McNamara et al. · British Journal of Pharmacology · 2019 · 45 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Acute neuroinflammation, sickness behavior and working memory responses to acute systemic LPS challenge following noradrenergic lesion in mice

Eoin O′Neill, Éadaoin W. Griffin, Ruairi O'Sullivan et al. · Brain Behavior and Immunity · 2020 · 35 citations · Full text

Life Sciences, Neurobiology, Neuroscience +14

Treatment with the noradrenaline re-uptake inhibitor atomoxetine alone and in combination with the α2-adrenoceptor antagonist idazoxan attenuates loss of dopamine and associated motor deficits in the LPS inflammatory rat model of Parkinson’s disease

Justin Yssel, Eoin O′Neill, Yvonne M. Nolan et al. · Brain Behavior and Immunity · 2018 · 30 citations

Medicine, Neuroscience, Pharmacology +17

Fingolimod Rescues Demyelination in a Mouse Model of Krabbe's Disease

Sibylle Béchet, Sinéad A. O’Sullivan, Justin Yssel et al. · Journal of Neuroscience · 2020 · 28 citations · Full text

Medicine, Neurology, Pharmacology +16

Efficacy, Safety, and Biomarker Analysis of 5 Mg and 7.5 Mg Doses of Crizanlizumab in Patients with Sickle Cell Disease: Primary Analyses from the Phase III STAND Study

Miguel R. Abboud, Rodolfo Delfini Cançado, Mariane de Montalembert et al. · Blood · 2023 · 28 citations

Medicine, Pharmacology, Pharmacotherapy +4